Itolizumab

'Don't prescribe Pirfenidone, Methylene blue': Centre issues FAQs to doctors on Covid-19 treatment

'Don't prescribe Pirfenidone, Methylene blue': Centre issues FAQs to doctors on Covid-19 treatment

Sumi Sukanya Dutta

02 Sep 2020

2 min read

Health ministry decides against including Itolizumab in clinical management protocols for COVID-19

Health ministry decides against including Itolizumab in clinical management protocols for COVID-19

From our online archive

26 Jul 2020

1 min read

Phase IV trials of Itolizumab to begin soon in Bengaluru

Phase IV trials of Itolizumab to begin soon in Bengaluru

Chetana Belagere

26 Jul 2020

2 min read

COVID-19 task force not in favour of itolizumab for treatment, says evidence 'inconclusive'

COVID-19 task force not in favour of itolizumab for treatment, says evidence 'inconclusive'

Sumi Sukanya Dutta

25 Jul 2020

2 min read

Regulator waived phase three trial to clear COVID-19 drug Itolizumab as India cases continue to rise

Regulator waived phase three trial to clear COVID-19 drug Itolizumab as India cases continue to rise

Sumi Sukanya Dutta

14 Jul 2020

2 min read

Biocon gets DCGI nod for use of Itolizumab for treatment of COVID-19 patients

Biocon gets DCGI nod for use of Itolizumab for treatment of COVID-19 patients

From our online archive

11 Jul 2020

2 min read

Drug regulator okays restrictive use of Psoriasis injection Itolizumab to treat Covid-19 patients

Drug regulator okays restrictive use of Psoriasis injection Itolizumab to treat Covid-19 patients

Sumi Sukanya Dutta

11 Jul 2020

2 min read

X